BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531541

KOBO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KOBO BIOTECH LIMITED Share Price Update

As of the latest trading session, KOBO BIOTECH LIMITED share price is currently at ₹ 2.49, which is down by ₹ -0.12 from its previous closing. Today, the stock has fluctuated between ₹ 2.49 and ₹ 2.64. Over the past year, KOBO BIOTECH LIMITED has achieved a return of -42.79 %. In the last month alone, the return has been -5.41 %. Read More...

KOBO BIOTECH LIMITED fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    6.00

  • P/E Ratio (TTM)

    -1.24

  • Beta

    0.32

  • Book Value / share

    -55.78

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -1.33

info icon alternate text

KOBO BIOTECH LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Company Name Price P/E P/B Market Cap 52 Week Low/High
Company Name Price P/E P/B Market Cap 52 Week Low/High

KOBO BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
2.50 -4.58 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 2.60
  • 26 Days 2.70
  • 10 Days 2.60
  • 50 Days 2.80
  • 12 Days 2.60
  • 100 Days 2.90
  • 20 Days 2.70
  • 200 Days 3.10
2.59 PIVOT

First Support

2.53

First Resistance

2.68

Second Support

2.44

Second Resistance

2.74

Third Support

2.38

Third Resistance

2.83

RSI

44.64

ADX

17.39

MACD

-0.07

Williams % R

-65.85

Commodity Channel Index (CCI)

-83.85

Date

2025-06-13

Week

22197.00

Same Day

20456.00

Month

12046.00

1 Year

0.33

3 Year

0.28

Over 1 Month

-5.41%

down

Over 1 Year

-42.79%

down

Over 3 Months

-5.07%

down

Over 3 Years

-21.02%

down

Over 6 Months

-30.13%

down

Over 5 Years

4.72%

down

KOBO BIOTECH LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

KOBO BIOTECH LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2012 1.0 Final 25 Sep 2012 Equity shares
22 Jul 2011 1.0 Final 26 Jul 2011 Equity shares
23 Sep 2010 1.0 Final 25 Sep 2010 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

KOBO BIOTECH LIMITED Share Price

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992. Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited. The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA).

The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides.

The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US. XTP shall be the technical supervisor for the transfer of technology, while SMEC shall supply the technical knowhow.

The company has bagged the award for the Best New Product manufactured in the State of Andhra Pradesh as awarded by the Federation of Andhra Pradesh Chamber of Commerce and Industry and also certified as an ISO 9002 company by American Quality Asseassors accredited with ANSI-RAB for the manufacturing and marketing MMAA, MMAE, DEA, EEAA and Aralydes.

The company had developed technology for recovery of Diketene from sludge. The company has also diversified into Bio-Technology, where the value addition is high. To part finance its biotech project the company has made a preferential issue of 1800000 Equity shares at Rs. 38.75 each aggregating to Rs. 697.50 lacs and issued 400000 warrants convertible into 400000 equity shares during the year 1999-2000.

The Bio-Technology Plant is located at Solapur,Maharashtra for manufacture of Ephedrine and Pseudo-Ephedrine with an installed capacity of 150 MT p.a. The plant has commenced operations during April 2001. The biotech division produces Pharmaceutical intermediates i.e Pseudoephedrine and ephedrine.

The company has signed two longterm export contracts to supply fixed quantities of Pseudoephedrine and is in talks with a few more MNC's for long term contracts during the year 2001-02. The company's bio-tech division is pursuing USFD approval which will enable it to enter into regulated markets.

The company is all set to introduce two high value added intermediates in its Diketene Division.The company has already completed trial production for these two pharmaceutical products and is ready for commercial launch.The company is expected an additional turnover of Rs.12 crores from these products from the year 2005-06.

During the year 2004-05, the Company increased its production capacity in Biotech Division. Further the company has increased the storage capacity of molasses from 2000 tons to 6000 tons.

The Company in 2006-07 had received USFDA approval for its facilities at Biotech Division, at Solapur, Maharashtra for manufacture of Psuedoephedrine.

Pursuant to the preferential issue of 98,09,100 equity shares [43.60% of the total paid-up equity share capital] of the Company to Arch Pharmalabs Limited in November, 2007, the SEBI [Substantial Acquisition of Shares and Takeovers] Regulations, 1997 were attracted and accordingly Arch Pharmalabs Limited, a Mumbai based Company engaged in business of manufacturing Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, was obligated to acquire upto 45,00,000 equity shares of Rs.10/- each representing 20% of the share capital of the Company.

Further, on receipt of SEBI approval for the Open Offer vide SEBI letter dated 11th November, 2008, the Open Offer continued from 3rd December, 2008 till 22nd December, 2008. Pursuant to the closure of the Offer, 45,00,000 equity shares were accepted in the Open Offer at an offer price of Rs. 21.85 for each equity share and subsequently transferred to Arch Pharmalabs Limited, on 31 January, 2009. Post-transfer, the shareholding of Arch Pharmalabs Limited in the Company was 1,43,09,100 equity shares comprising 63.60% of the total equity capital of the Company. Pursuant to Arch Pharmalabs Limited acquiring a majority stake of 63.60% in the Company, the Company became a subsidiary of Arch Pharmalabs Limited.

Regal Pharma PTE Ltd. was formed as wholly owned subsidiary company in Singapore on May 15, 2010.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kobo Biotech Ltd?

Answer Field

Kobo Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 2.50 as on Jun 16 2025 03:25 PM.

What is the Market Cap of Kobo Biotech Ltd Share?

Answer Field

The market cap of Kobo Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 6.00 as on Jun 16 2025 03:25 PM.

What is the 52 Week High and Low of Kobo Biotech Ltd?

Answer Field

The 52 Week High and Low of Kobo Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 4.79 and ₹ 2.48.

What is 1 year return for Kobo Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -42.79%.

What is the P/E Ratio of Kobo Biotech Ltd Share?

Answer Field

As on Jun 16 2025 03:25 PM the price-to-earnings (PE) ratio for Kobo Biotech Ltd share is -1.24.

What is the PB ratio of Kobo Biotech Ltd Share?

Answer Field

As on Jun 16 2025 03:25 PM, the price-to-book (PB) ratio for Kobo Biotech Ltd share is -55.78.

How to Buy Kobo Biotech Ltd Share?

Answer Field

You can trade in Kobo Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kobo Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Kobo Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kobo Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|